News
-
-
-
COMMUNIQUÉ DE PRESSE
ROK Resources Files Financial Results for the Third Quarter of 2025 and Provides Update on Going Private Transaction
ROK Resources Inc. provides an update on the Going Private Transaction anticipated to close before December 31, 2025, and highlights Q3 2025 financial and operating performance -
COMMUNIQUÉ DE PRESSE
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve
enVVeno Medical Corporation receives unfavorable FDA decision on VenoValve, plans to focus on next-generation venous valve enVVe. Company has sufficient cash for operations into 2027. Severe CVI impacts millions in the U.S -
COMMUNIQUÉ DE PRESSE
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
Nanobiotix announces advancements in Curadigm Nanoprimer platform with new patent applications, pre-clinical data, and external collaborations, aiming to revolutionize drug delivery -
COMMUNIQUÉ DE PRESSE
NANOBIOTIX annonce les avancées de sa plateforme de nanoprimer Curadigm avec une mise à jour des plans de développement pour son pipeline interne et des collaborations externes
Nanobiotix annonce les avancées de sa plateforme de Nanoprimer Curadigm avec une mise à jour des plans de développement pour son pipeline interne et des collaborations externes -
-
-
-
COMMUNIQUÉ DE PRESSE
Horizon Kinetics Holding Corporation Reports Third Quarter Results
Horizon Kinetics Holding Corporation reported strong financial results for Q3 2025 with increased management and advisory fee revenue, net income, and assets under management. The company also declared a dividend and will host a conference call
